Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2013 Mar 31;71(6):1531–1540. doi: 10.1007/s00280-013-2152-7

Figure 1.

Figure 1

Patient-reported pain and numbness by QST baseline deficit category. A, Pain reported during induction therapy. B, Numbness reported during induction therapy. C, Pain reported during maintenance therapy. D, Numbness reported during maintenance therapy. *Asterisks indicate P < 0.008.